Skip to Content

Dermaxon Logo Dermaxon

Further exploring the brain-skin connection for a better life

Working on reversing the biological mechanisms underlying the aging process

Tremendous advances in health care and medical discovery have changed our control of the aging process. Our goal at DermaXon is to slow the underlying biological mechanisms of aging and delay or prevent the onset of age-related  diseases. This includes investigating the biology of skin, and the neurodegenerative diseases associated with the aging brain and pain.

Learn More

Our Technologies

DermaXon was founded in 2013. We provide formulated first-in-class molecules across the following therapeutic areas: Alzheimer’s disease, Parkinson’s disease, Skin conditions and Pain.

LEARN MORE

Pathologies

Dermaxon provides formulated first-in-class molecules across the following therapeutic areas:
  • Alzheimer’s disease
  • Parkinson’s disease
  • Pain
  • Ichthyosis
  • Acne

News

June 2018

DermaXon received a Phase 1 STTR Grant funding from the National... Read More

May 2018

DermaXon presented at the 2018 Society for Investigative Dermatology... Read More

April 2017

DermaXon won the “Shark Tank” pitching competition... Read More

April 2017

DermaXon presented at the 2017 Society for Investigative Dermatology... Read More

^ Back to Top
MENU